June 2023 Issue Table Of Contents

From The Editor

• More Transparency, To A Point

Feature Articles

• From Biggest Pharma To Rare Disease Start-Up
• Leading Aulos Bioscience’s “Triumvirate” Model

Companies To Watch

• Companies To Watch: Orca Bio

Industry Leader

• Key Questions To Ask When Entering A Pharma Partnership
• Clinical Trials Vendor-Management Best Practices

Industry Research

• Attributes Gaining Importance When Selecting Among Preferred Providers For Phase 1 Services

Podcast Summary

• Where Science Leads, Business Follows

Inside The Industry

• 8 Strategies For Leading High-Performing Hybrid Teams In Clinical Research
• Strategizing The Scale-Up Of Cell Therapy Manufacturing Capacity
• A Quick Transition To Late-Stage Clinical Trials
• Why Your Clinical Operations Must Have A Metrics-Driven Culture
• Phase 2/3 Outsourced Spend Across Provider Types
• Entrepreneurs In Residence Program Advises NC Bioscience Startups
• New DSCSA Compliance Blueprint Includes FDA & Industry Input
• Effective Project Leadership In The Medical Device Industry

Leadership Lessons

• Why Leaders Need To Learn To Stay Calm In A Crisis

Ask The Board

• In Partnering With Academic Institutions To Advance Drug Discovery, What Are The Key Benefits And Challenges?
• In Discussing A Strategic Initiative Presented To The Board By Management, Such As A Bolt-On Acquisition, What Are The Three Core Questions That Boards Should Always Ask?

---

2023 CRO Leadership Awards

• Navigating The Complexities Of CRO Selection

Winners List